abstract |
The present invention relates to a protein capable of inhibiting the activity of PKC and a pharmaceutical composition comprising the same, more specifically, a nucleic acid molecule encoding a protein capable of inhibiting PKC activity, a vector comprising the nucleic acid molecule and Cells provided herein, the proteins and compositions of the present invention can prevent or treat tumors caused by PKC activity. |